Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania

Autor: Cs, Dukes, Jeremy Sugarman, Jp, Cegielski, Gj, Lallinger, Dh, Mwakyusa

Publikováno v: Europe PubMed Central

Concurrent infection with HIV-1 and Mycobacterium tuberculosis is increasingly common in East Africa. In the past, a drug regimen consisting of 2 months of intramuscular streptomycin plus 12 months of isoniazid and thiacetazone has been used in tuber

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::95ed55fde482c394a3df3fa3df645c28
https://pubmed.ncbi.nlm.nih.gov/1284179

Association of smoking and alcohol use with rifampin-resistant TB treatment outcomes.

Autor: Campbell JR; Department of Medicine & Department of Global and Public Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada, McGill International TB Centre, Montreal, QC, Canada, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada., Chan ED; Department of Medicine, Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, CO, USA, Department of Academic Affairs, National Jewish Health, Denver, CO, USA, Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora, CO, USA., Anderson LF; Strategic Information for Response, Global Malaria Programme, World Health Organization, Geneva, Switzerland., Bonnet M; University of Montpellier, Recherches Translationnelles sur le VIH et les Maladies Infectieuses, Institut de Recherche pour le Developpement, Institut national de la santé et de la recherche médicale (INSERM), Montpellier, France, Epicentre, Paris, France., Brode SK; Department of Respiratory Medicine, West Park Healthcare Centre, Toronto, ON Canada, Department of Medicine, Division of Respirology, University Health Network, Toronto, ON Canada, Department of Medicine, University of Toronto, Toronto, ON Canada., Cegielski JP; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Guglielmetti L; Sorbonne Université, Centre d´Immunologie et des Maladies Infectieuses (Cimi-Paris), INSERM, U1135, Paris, France, Assistance Publique Hôpitaux de Paris Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Laboratoire de Bactériologie-Hygiène, Hôpital Pitié-Salpêtrière, Paris, France., Singla R; Department of TB and Respiratory Diseases, National Institute of TB and Respiratory Diseases, New Delhi, India., Fox GJ; University of Sydney, Sydney, NSW, Australia., Skrahina A; Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus., Rodrigues D; Instituto Clemente Ferreira, São Paulo, SP, Brazil., Kuksa L; Department of MDR TB, Riga East University Hospital, Riga, Latvia., Viiklepp P; Department of Registries, National Institute for Health Development, Tallinn, Estonia., Menzies D; McGill International TB Centre, Montreal, QC, Canada, Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, Montreal, QC, Canada, Department of Epidemiology, Biostatistics, and Occupational Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada.

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2023 Apr 01; Vol. 27 (4), pp. 338-340.

A University-Led Contact Tracing Program Response to a COVID-19 Outbreak Among Students in Georgia, February-March 2021.

Autor: Harrington KRV; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Siira MR; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Rothschild EP; Student Health Services, Emory University, Atlanta, GA, USA., Rabinovitz SR; Student Health Services, Emory University, Atlanta, GA, USA., Shartar S; Office of Critical Event Preparedness and Response, Emory University, Atlanta, GA, USA., Clark D; Division of Campus Life, Emory University, Atlanta, GA, USA., Isakov A; Office of Critical Event Preparedness and Response, Emory University, Atlanta, GA, USA., Chamberlain A; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Gelaye E; Division of Campus Life, Emory University, Atlanta, GA, USA., Cegielski JP; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Gandhi NR; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.; Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.; Division of Infectious Diseases, Department of Medicine, Emory School of Medicine, Emory University, Atlanta, GA, USA.

Publikováno v: Public health reports (Washington, D.C. : 1974) [Public Health Rep] 2022 Nov-Dec; Vol. 137 (2_suppl), pp. 61S-66S. Date of Electronic Publication: 2022 Aug 20.

Avoiding pitfalls in calculating the population attributable fraction of undernutrition for TB.

Autor: Sinha P; Department of Medicine, Section of Infectious Diseases, Boston Medical Center, Boston, MA., White LF; Department of Biostatistics, Boston University School of Public Health, Boston, MA., Hochberg NS; Department of Medicine, Section of Infectious Diseases, Boston Medical Center, Boston, MA, Department of Epidemiology, Boston University School of Public Health, Boston, MA., Cegielski JP; Department of Epidemiology, Rollins School of Public Health, Atlanta, GA, USA.

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2022 Jan 01; Vol. 26 (1), pp. 80.

Evidence-based Definition for Extensively Drug-Resistant Tuberculosis.

Autor: Roelens M; Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Battista Migliori G; Istituti Clinici Scientifici Maugeri, Istituto di Ricovero e Cura a Carattere Scientifico, Tradate, Italy., Rozanova L; Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Estill J; Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Institute of Mathematical Statistics and Actuarial Science, University of Bern, Bern, Switzerland., Campbell JR; McGill International Tuberculosis Centre, McGill University, Montreal, Quebec, Canada.; Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University Health Centre, Montreal, Quebec, Canada., Cegielski JP; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia., Tiberi S; Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.; Division of Infection, Royal London Hospital, Barts Health National Health Service Trust, London, United Kingdom., Palmero D; Hospital F. J. Muñiz, Buenos Aires, Argentina., Fox GJ; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Guglielmetti L; Équipe 13, Centre d'Immunologie et des Maladies Infectieuses, Sorbonne Université, Unité 1135, Institut National de la Santé et de la Recherche Médicale, Paris, France.; Centre National de Référence des Mycobactéries et de la Résistance des Mycobactéries aux Antituberculeux, Hôpital Pitié-Salpêtrière, Groupe Hospitalier Universitaire Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Paris, France., Sotgiu G; Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy., Brust JCM; Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York., Bang D; Statens Serum Institut, Copenhagen, Denmark.; Department of Clinical Microbiology, Copenhagen University Hospital Amager and Hvidovre, Copenhagen, Denmark., Lienhardt C; Unité Mixte Internationale TransVIHMI (Université de Montpellier, UMI 233 IRD, U1175 INSERM), Institut de Recherche pour le Développement, Montpellier, France.; Epidemiology and Population Health, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Lange C; German Center for Infection Research Clinical Tuberculosis Center, Research Center Borstel, Borstel, Germany.; Department of Respiratory Medicine and International Health, University of Lübeck, Lübeck, Germany.; Global Tuberculosis Program, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas; and., Menzies D; McGill International Tuberculosis Centre, McGill University, Montreal, Quebec, Canada.; Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University Health Centre, Montreal, Quebec, Canada., Keiser O; Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland., Raviglione M; Centre for Multidisciplinary Research in Health Science, University of Milan, Milan, Italy.

Publikováno v: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2021 Sep 15; Vol. 204 (6), pp. 713-722.